TrianglePUBLICATIONS · 36996373
Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2023 Jun 1
- First author
- Huang H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Huang H
- type
- Author
- name
- Tao R
- type
- Author
- name
- Hao S
- type
- Author
- name
- Yang Y
- type
- Author
- name
- Cen H
- type
- Author
- name
- Zhou H
- type
- Author
- name
- Guo Y
- type
- Author
- name
- Zou L
- type
- Author
- name
- Cao J
- type
- Author
- name
- Huang Y
- type
- Author
- name
- Jin J
- type
- Author
- name
- Zhang L
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Huang H
- type
- Author
- name
- Tao R
- type
- Author
- name
- Hao S
- type
- Author
- name
- Yang Y
- type
- Author
- name
- Cen H
- type
- Author
- name
- Zhou H
- type
- Author
- name
- Guo Y
- type
- Author
- name
- Zou L
- type
- Author
- name
- Cao J
- type
- Author
- name
- Huang Y
- type
- Author
- name
- Jin J
- type
- Author
- name
- Zhang L
- type
- Author
- bibliography ids
- nci-bib-5ec4f3c35eb50b28521b6672
- book metadata
- content sha256
- 30a6a2d6125f4b895628fce4d25912e082d20926a28fa4198c7230e97066adf9
- document type
- citation
- dois
- 10.1200/JCO.22.02367
- electronic publication date
- display
- 2023 Mar 30
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36996373
- immutable id
- pubmed:36996373@30a6a2d6125f4b895628fce4d25912e082d20926a28fa4198c7230e97066adf9
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 16
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3032-3041
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 36996373
- provenance
- batch id
- 5329a5d0877ee70ecd11
- provider
- NCBI PubMed ESummary
- record sha256
- 1df3ca47cf68fedb9224e1c7066986e4cf27b59970b1bd202ec572bae79f909b
- response sha256
- bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
- retrieved at
- 2026-09-09T23:48:15.763286+00:00
- publication date
- display
- 2023 Jun 1
- precision
- day
- year
- 2023
- publication types
- Clinical Trial, Phase II
- Multicenter Study
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study.
Preserved source evidence · Independent clinical review pending · Not medical advice